NeuroMolecular Medicine

, Volume 4, Issue 1–2, pp 1–5 | Cite as

Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses

Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Auluck P. K. and Bonini N. M. (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat. Med. 8, 1185–1186.PubMedCrossRefGoogle Scholar
  2. Auluck P. K., Chan H. Y. E., Trojanowski J. Q., Lee V. M.-Y., and Bonini N. M. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model of Parkinson’s disease. Science 295, 865–868.PubMedCrossRefGoogle Scholar
  3. Bonini N. M. (2002) Chaperoning brain degeneration. Proc. Natl. Acad. Sci. USA 99, 16407–16411.PubMedCrossRefGoogle Scholar
  4. Bucciantini M., Giannoni E., Chiti F., et al. (2002) Inherent toxicity of aggregates implies a common mechanism of protein misfolding disease. Nature 416, 507–511.PubMedCrossRefGoogle Scholar
  5. Giasson B. I., Forman M. S., Higuchi M., et al. (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science. 300, 636–639.PubMedCrossRefGoogle Scholar
  6. Giasson B. I., Lee V. M.-Y., Ischiropoulos H., and Trojanowski J. Q. (2002a) The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s disease. Free Radic. Biol. Med. 32, 1264–1275.PubMedCrossRefGoogle Scholar
  7. Giasson B. I., Duda J. E., Murray I. V., et al. (2002b) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 290, 985–989.CrossRefGoogle Scholar
  8. Hardy J., Duff K., Hardy K. G., Perez-Tur J., and Hutton M. (1998) Genetic dissection of Alzheimer’s disease and related dementias: amyloid and its relationship to tau. Nat. Neurosci. 1, 355–358.PubMedCrossRefGoogle Scholar
  9. Hardy J. (1997) Amyloid the presenilins and Alzheimer’s disease. Trends Neurosci. 20, 154–159.PubMedCrossRefGoogle Scholar
  10. Hardy J. and Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmcol. Sci. 12, 383–388.CrossRefGoogle Scholar
  11. Irizarry M. C. and Hyman B. T. Alzheimer disease therapeutics. (2001) J. Neuropath. Exp. Neurol. 60, 923–928.PubMedGoogle Scholar
  12. Lee V. M.-Y., Goedert M., and Trojanowski J. Q. (2001) generative tauopathies. Annu. Rev. Neurosci. 24, 21–1159.CrossRefGoogle Scholar
  13. Loo T. W. and Clarke D. M. (2003) Application of chemical chaperones to the rescue of folding defects. Methods Mol. Biol. 232, 231–244.PubMedGoogle Scholar
  14. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic. Biol. Med. 20, 154–159.Google Scholar
  15. Mattson M. P. (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol. Med., 3, 65–94.CrossRefGoogle Scholar
  16. Mattson M. P., Chan S. L., and Duan W. (2002) Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 82, 637–672.PubMedGoogle Scholar
  17. Mayeux R. and Sano M. (1999) Treatment of Alzheimer’s disease. N. Engl. J. Med. 341, 1670–1679.PubMedCrossRefGoogle Scholar
  18. Mudher A. and Lovestone S. (2002) Alzheimer’s disease—do tauists and Baptists finally shake hands? Trends Neurosci. 25, 22–26.PubMedCrossRefGoogle Scholar
  19. Soto C. (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49–60.PubMedCrossRefGoogle Scholar
  20. Taylor J. P., Hardy J., and Fischbeck K. H. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991–1995.PubMedCrossRefGoogle Scholar
  21. Trojanowski J. Q. and Lee V. M-Y. (2003) Parkinson’s disease and related alpha-synucleinopathies are brain amyloidoses. Ann. NY Acad. Sci. 991, 107–111.PubMedCrossRefGoogle Scholar
  22. Welch W. J. and Gambetti P. (1998) Chaperoning brain diseases. Nature 392, 23–24.PubMedCrossRefGoogle Scholar
  23. Trojanowski J. Q. (2002) Emerging Alzheimer’s disease therapies: focusing on the future. Neurobiol Aging 23, 985–990.PubMedCrossRefGoogle Scholar
  24. Trojanowski J. Q. and Lee V. M.-Y. (2000) “Fatal attractions” of proteins: a comprehensive hypothetical mechanism underlying Alzheimer’s disease and other neurodegenerative disorders. Ann. N Y Acad. Sci. 924, 62–67.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2003

Authors and Affiliations

  1. 1.The Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute on AgingUniversity of Pennsylvania School of MedicinePhiladelphia
  2. 2.Laboratory of NeurosciencesNational Institute on Aging Intramural Research ProgramBaltimore

Personalised recommendations